226 related articles for article (PubMed ID: 17082660)
1. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection.
Horton H; Frank I; Baydo R; Jalbert E; Penn J; Wilson S; McNevin JP; McSweyn MD; Lee D; Huang Y; De Rosa SC; McElrath MJ
J Immunol; 2006 Nov; 177(10):7406-15. PubMed ID: 17082660
[TBL] [Abstract][Full Text] [Related]
2. Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines.
Borthwick N; Lin Z; Akahoshi T; Llano A; Silva-Arrieta S; Ahmed T; Dorrell L; Brander C; Murakoshi H; Takiguchi M; Hanke T
PLoS One; 2017; 12(4):e0176418. PubMed ID: 28448594
[TBL] [Abstract][Full Text] [Related]
3. Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles.
Streeck H; Lichterfeld M; Alter G; Meier A; Teigen N; Yassine-Diab B; Sidhu HK; Little S; Kelleher A; Routy JP; Rosenberg ES; Sekaly RP; Walker BD; Altfeld M
J Virol; 2007 Jul; 81(14):7725-31. PubMed ID: 17494064
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
[TBL] [Abstract][Full Text] [Related]
5. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
[TBL] [Abstract][Full Text] [Related]
6. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.
Altfeld M; Kalife ET; Qi Y; Streeck H; Lichterfeld M; Johnston MN; Burgett N; Swartz ME; Yang A; Alter G; Yu XG; Meier A; Rockstroh JK; Allen TM; Jessen H; Rosenberg ES; Carrington M; Walker BD
PLoS Med; 2006 Oct; 3(10):e403. PubMed ID: 17076553
[TBL] [Abstract][Full Text] [Related]
7. Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.
Serwanga J; Nakiboneka R; Mugaba S; Magambo B; Ndembi N; Gotch F; Kaleebu P
Vaccine; 2015 Mar; 33(14):1664-72. PubMed ID: 25728323
[TBL] [Abstract][Full Text] [Related]
8. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
Ferrari G; Neal W; Ottinger J; Jones AM; Edwards BH; Goepfert P; Betts MR; Koup RA; Buchbinder S; McElrath MJ; Tartaglia J; Weinhold KJ
J Immunol; 2004 Aug; 173(3):2126-33. PubMed ID: 15265949
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
[TBL] [Abstract][Full Text] [Related]
10. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
[TBL] [Abstract][Full Text] [Related]
11. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
Altfeld M; Addo MM; Rosenberg ES; Hecht FM; Lee PK; Vogel M; Yu XG; Draenert R; Johnston MN; Strick D; Allen TM; Feeney ME; Kahn JO; Sekaly RP; Levy JA; Rockstroh JK; Goulder PJ; Walker BD
AIDS; 2003 Dec; 17(18):2581-91. PubMed ID: 14685052
[TBL] [Abstract][Full Text] [Related]
12. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
[TBL] [Abstract][Full Text] [Related]
13. Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.
Lopes AR; Jaye A; Dorrell L; Sabally S; Alabi A; Jones NA; Flower DR; De Groot A; Newton P; Lascar RM; Williams I; Whittle H; Bertoletti A; Borrow P; Maini MK
J Immunol; 2003 Jul; 171(1):307-16. PubMed ID: 12817012
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376
[TBL] [Abstract][Full Text] [Related]
15. Multiple T-cell epitopes overlap positively-selected residues in the p1 spacer protein of HIV-1 gag.
Semeniuk CA; McKinnon L; Peters HO; Gubbins M; Mao X; Ball TB; Luo M; Plummer FA
AIDS; 2009 Apr; 23(7):771-7. PubMed ID: 19287301
[TBL] [Abstract][Full Text] [Related]
16. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
Jansen CA; Kostense S; Vandenberghe K; Nanlohy NM; De Cuyper IM; Piriou E; Manting EH; Miedema F; van Baarle D
Eur J Immunol; 2005 Jan; 35(1):150-8. PubMed ID: 15593302
[TBL] [Abstract][Full Text] [Related]
17. A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.
Mothe B; Hu X; Llano A; Rosati M; Olvera A; Kulkarni V; Valentin A; Alicea C; Pilkington GR; Sardesai NY; Rocafort M; Crespo M; Carrillo J; Marco A; Mullins JI; Dorrell L; Hanke T; Clotet B; Pavlakis GN; Felber BK; Brander C
J Transl Med; 2015 Feb; 13():60. PubMed ID: 25879820
[TBL] [Abstract][Full Text] [Related]
18. Selective Upregulation of CTLA-4 on CD8+ T Cells Restricted by HLA-B*35Px Renders them to an Exhausted Phenotype in HIV-1 infection.
Elahi S; Shahbaz S; Houston S
PLoS Pathog; 2020 Aug; 16(8):e1008696. PubMed ID: 32760139
[TBL] [Abstract][Full Text] [Related]
19. Elevated HIV Infection of CD4 T Cells in MRKAd5 Vaccine Recipients Due to CD8 T Cells Targeting Adapted Epitopes.
Qin K; Boppana S; Carlson JM; Fiore-Gartland A; Files J; Zeng J; Edberg J; Mailliard RB; Ochsenbauer C; Bansal A; Goepfert P
J Virol; 2021 Jul; 95(16):e0016021. PubMed ID: 34076482
[TBL] [Abstract][Full Text] [Related]
20. Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapy.
Yang H; Dong T; Turnbull E; Ranasinghe S; Ondondo B; Goonetilleke N; Winstone N; di Gleria K; Bowness P; Conlon C; Borrow P; Hanke T; McMichael A; Dorrell L
J Immunol; 2007 Jul; 179(1):597-606. PubMed ID: 17579081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
